Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Role of Anti-Inflammatory Agents in Patients With Schizophrenia
The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2009
by Pakistan Institute of Learning and Living.
Recruitment status was Recruiting
Study NCT00929955 Information provided by Pakistan Institute of Learning and Living
First Received on June 28, 2009. Last Updated on June 29, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Schizophrenia
Schizoaffective Disorder
Psychosis Not Otherwise Specified
Schizophreniform Disorder
Additional conditions recognized in this trial
Mental Disorders
Psychotic Disorders
More general conditions related to this trial
Schizophrenia and Disorders with Psychotic Features
Interventions listed in this trial
Ondansetron
Simvastatin
Placebo
Additional drug interventions recognized in this trial
Anti-Inflammatory Agents
More general drug interventions related to this trial
Anti-Anxiety Agents
Anticholesteremic Agents
Antiemetics
Antimetabolites
Antipruritics
Antipsychotic Agents
Autonomic Agents
Central Nervous System Agents
Central Nervous System Depressants
Dermatologic Agents
Enzyme Inhibitors
Gastrointestinal Agents
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypolipidemic Agents
Lipid Regulating Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Serotonin Agents
Serotonin Antagonists
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
Pakistan Institute of Learning and Living
Karwan e Hayat
Dow University of Health Sciences
Back to top of Main Content
